News

Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance

Asieris Included in the SSE STAR Biology and Medicine Index

Highlights of Asieris 2022 Semi-Annual Report

Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy

Asieris on Science and Technology Innovation Board “2022 Most Innovative Companies” List

Now Hiring: Business Development Director (Remote)

Now Hiring: Biomarker Scientist (Onsite, Mountain View)

Now Hiring: Protein Scientist (Onsite, Mountain View)

Now Hiring: Bioinformatics Scientist (Onsite, Mountain View)

Now Hiring: Research Associate or Sr. RA (Onsite, Mountain View)